Induction of specific T-cell responses in HIV infection
Abstract
The results clearly show that restoration of HIV-specific T-cell immunity occurs after immunization with the HIV gp160 antigen and is not influenced by the addition of antiviral monochemotherapy. Even intensive chemotherapy alone did not restore HIV-specific immunity and immunization alone did not i …
Keywords
vaccination
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
Clinical Trial
Receptors
controlled clinical trial
vaccines
anti-hiv agents / therapeutic use
combined modality therapy
apoptosis
disease progression
cd4 lymphocyte count
hiv infections / immunology*
hiv infections / virology
viral load
phase i
synthetic / immunology
synthetic / therapeutic use
zidovudine / therapeutic use
lymphocyte activation
t-lymphocytes / immunology*
hiv-1 / immunology*
antigen
t-cell
pmid:9468364
doi:10.1097/00002030-199802000-00005
a c leandersson
g bratt
b wahren
aids vaccines / immunology
aids vaccines / therapeutic use*
hiv antigens / immunology
hiv envelope protein gp160
hiv infections / therapy
hiv-1 / physiology
alpha-beta / analysis
ccr5 / genetics
Access
Citation
ID:
268063
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
268063
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet